Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Complete Revascularisation Following Acute MI
Author(s): Ahmed Gonnah , Nadhrah Darke , Liam Mullen , et al Added: 3 months ago

MI/ACS

Prevention & Chronic Conditions
Revascularisation for Ischaemic Cardiomyopathy
Author(s): Matthew E Li Kam Wa , Saba Z Assar , Ajay J Kirtane , et al Added: 1 year ago

Heart Failure

Intervention
EuroPCR 25: The DANAMI-3-PRIMULTI Trial
Author(s): Thomas Engstrøm Added: 1 month ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete… View more

Demographic

MI/ACS
TCT 23: IFR SWEDEHEART
Author(s): Matthias Gotberg Added: 1 year ago
TCT 23 - We are joined by Dr Matthias Götberg (Lund University, SE) to discuss recent findings from a study of the SWEDEHEART Registry, where the long-term outcomes of iFR vs FFR guided coronary revascularization were compared. Results suggest that in a national registry analysis of 42887 patients investigated with iFR or FFR with 5-year follow-up, similar outcomes were observed in MACE, all… View more

Intervention

Prevention & Chronic Conditions
ESC 24: The EARTH-STEMI Meta-Analysis
Author(s): Gianluca Campo Added: 10 months ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in… View more

Intervention
LINC 2025: 12-Month Amputation and Readmission Rates from TRUE-PTX
Author(s): Marianne Brodmann Added: 5 months ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved… View more

Vascular Disease and Surgery

Intervention
Lukla Biasi
Research Area(s) / Expertise:

Peripheral Artery Disease - General

 Job title: Consultant Vascular & Endovascular Surgeon
Dr Lukla Biasi is an experienced vascular and endovascular surgeon with a dedicated commitment to the sub-specialties of lower limb revascularisation and carotid surgery. Lukla Biasi graduated with distinguished honours from the University of Bologna, Italy; following a research fellowship at St Georges’ Vascular Institute in London, he completed the specialist training at the University… View more
Research Area(s) / Expertise:
ESC 24: NOTION-3: FFR Guided PCI in TAVI
Author(s): Jacob Thomsen Lønborg Added: 10 months ago
ESC Congress 2024 — FFR-guided PCI improves outcomes in TAVI patients with coronary artery disease.Principal investigator, Prof Jacob Thomsen Lønborg (Rigshospitalet, DK) joins us to discuss the NOTION-3 trial (NCT03058627). A multinational, open-label, investigator-initiated trial evaluated the efficacy of FFR-guided PCI versus medical therapy in managing coronary artery disease (CAD) among… View more

Imaging & Diagnostics

Intervention
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr Sanjog Kalra is an Interventional Cardiologist at University of Toronto, Toronto, CA. He specialises in complex, high risk coronary revascularisation, chronic total occlusion and mechanical circulatory support. View more